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Cardiogenfc shock was present in 33 (14.2%) LAD and 31 (13.'P/o) RCA 
patients (p = NS). Major angiographio (major dissection, no-reflow, perfora- 
tion), and major clinical (abrupt closure, bypass surgery, death) events were 
reviewed. 
Conclusions: Despite similarities in baseline patient demographics, PTCA 
of the RCA was associated with more procedural complications than PTCA of 
the LAD, but this did not worsen in-hospital outcomes. Convemely, PTCA of 
the LAD was associated with an increase in major in-hospital cardiac events, 
mostly secondary to the risk of death in the presence of cardieganio shock. 
Therefore, when performing PTCA of the RCA, procedural details such as 
temporary pacing, defibrillation, intensive ant)coagulation, and management 
of no-raflow need to be considered. In contrast, for PTCA of the LAD, proce- 
dural complications are rare, but case selection and shock stgnHicantiy alter 
in-hospital outcome. 
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~"~ Prophy~ic Intmaortio Balloon Pumping for Acute 
Myocardial Infarction Does Not Improve Left 
Ventdeular Function 
Cindy L. Grines, Bruce R. Brodie, John J. Griffin, Bryan C, Donohue, 
C. Costantint, Carlos Bafastrinl, Gregg Stone, Thomas R Whadon, Jr., 
Uoudmila Mitina, Mar)ann Graham, Denise E, Jones, Dabra Sachs, William 
W. O'Neill, William Beaumont Hospital, Royal Oak, MI 
It has been suggested that the afterload reduction offered by inlraanrtic 
balloon counterpuisation 0ABP) may improve left ventricular performance or 
effect remodeling alter acute myocardial infarction. To investigate this issue, 
we randomized 437 high risk M110ts (age > 70, ejection fraction < 45%, 3 
vessel disease, suboptimal PTCA, SVG occlusion, ventricu'ar ant~thmlas) 
to receive or not receive IABP for 48 hours after- reperfusion with primap/ 
PTGA. Contrast left ventriculography was obtained acutely (prior to IABP) 
and repeated at 1 week. Radionuclide ventriculograpby was performed at 6 
weeks. 
Prophylactic IABP placement did not prevent hemedynamio deterioration 
as mffacted by in-hospital sustained hypetension, CHF, pulmonary edema, 
need for vasoprassom, or death. Furthermore, IABP did not influence global 
or legional LV function, as follows: 
LV Function IABP No IABP P 
El:: acute 46% 49% 0.01 
1 week improvement 1.4% 1.5% NS 
Infarct zone: acute -2.6 SD/Chord -2.6 SO/Chord NS 
1 week improvement 0.2 SD/Chord 0.3 SD/Chord NS 
EF: 6 week 48% 47% NS 
In conclusion, although IABP may be useful in treal/ng hemedynamic 
problems with AMI, prophylactic placement for 48 hrs does not prevent 
hemodynamic deterioration or influence left vantricular regional or global 
systolic function. 
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~ Simultaceous Glyceprotein Integdn Plate)st lib/Ills 
Blockade and Front-loaded Tissue Plasminogen 
Activator in Acute Myocardial infarction: Results 
From a Randomized Trial 
E. Magnus Ohman, Neat S, Klaiman, Gerald Gacloch, Seth Worlay, J. 
David Talley, Frank l. Nave))a, H. Vernon Anderson, Doug Spdggs, 
Michael Miller, Mark Cohen, Dean Kereiakas, Bany S. George, Kdstina 
N. Sigmon, Mitohell Krucoff, Robert M. Calitf, Eric J. Topoi far the 
IMPACT-AMI Group, Duke University, Durham, NC 
The platatet glycoprotain I(b/llla receptor blocker Integrslin in combination 
with accelerated tPA has been found to have a dose-dependant effect on 
ex-vivo piatelet aggregation. To evaluate the outcomes in tots with acute 
myocardial infarction receiving tPA, Integrelin, heparin, and aspidn, a double- 
blind randomized lrial was performed. After a dese-escalation phase an 
Integrafln dose of 180 ug/k0 bolus followed by 0.75 ug/kg infusion was 
selected and was sfudled in 51 pfa with 55 pts receiving placebo. Pts race)red 
a bolus within 10 rains of starling tPA and the infusion was continued for 24 
hours. All pts had 90 minute anglegmphy and 87 had 24-hour continuous ST 
segment monitoring. Pts allocated to lntegmlin had similar ates of severe 
Outcomes lntegmfln Placebo 
T1MI Grade 3 66% 39% 
Pelency (TIMI grade 2 + 3) 87% 69% 
Death 7.8% 3.6% 
tO Bleed 2% 0 
Reinfarction 0 3.6% 
CHF/Pulm edema 9.8% 7,3% 
p = O.Q06 
p = 0.01 
bleeding (4% vs 5%) ) and blood transfusions (16% vs 18%) compared with 
placebo 10is. Intagrelin treated pts had a shorter time to steady state (66 vs 
116 rains, p = 0.05), less recurrent iSchemia (31% vs 5(~,o, p = 0.t 3), and 
area under the ST curve during the first 6 hours (2868 vs 6670, p = 0.13) on 
ST monitoring. 
Conclusion: Potent platelet a~regation blockade using Integrelin during 
thrombolysis may be an attractive strategy to improve roper)us)on rates and 
reduce ischemia in acute myocardial infarction. 
I -~  Angiographle and Clinical Predictors of 
Outcome After Device Intervention 
Tuesday, March 26, 1995, 2:00 p.m.-3:30 p.m. 
Orange County Convention Center, Room 314 
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~ A  Mete-Analysb on the Clinical and Angiographic 
Outcomes of S tem vs PTCA in the Different 
Coronary V ~  in the Benestent.1 and Stress 1 
and 2 Trials 
Sheldon Gold'oerg, Aida J. Azar, Ferdinand Kiemonij, Peter de Jaegare, 
Richard Schatz, Donald Bairn, Martin Leon, Paldck W. Sen'uys. Cardialysis, 
Rotterdam; The Netherlands 
Both the Benestent and Stress 1 and 2 trials compared elective Palmaz- 
Schatz stent (St vs balloon angioplasty (PTCA) in denovo lesions. These 
trials demonstrated that S improve the angiographio and clinical outcomes. To 
determine the impact of S vs PTCA in reducing ~ clinical and angiographio 
events, we analysed the data according to lesion location. The results were 
as follows: 
LAD PTCA LAD S RCA RCA S LCX LCX S 
PTCA PTCA 
(n=293) (n=307} (n=176) (n=151) (n=54| (n=78) 
Event 101(34%) 75(24%) 44(25%) 25(17%) 12(22%) 16(21%) 
Pcuto gain 1.04 1.47 1.18 1.72 1.16 1.65 
Late loss 0.45 0.72 032 0.64 0.33 0.70 
Net gain 0.67 0.74 0.84 1.07 0.85 0.94 
Restenosis 110(43%) 74(27%) 45(32%) 30(23%) 15(32%) 18(25%) 
%0S FUP 48:1:18 42~19 42 d: 16 38:1:16 41+19 39±19 
MLD FUP 1.50 1.69 1.78 1.95 1.74 1.77 
Event, dead/mi/cabg/ptca; restenosis, > 50% d'mrneter stenosis follow-up; mid, minimal 
tureen diarmate~, %DS, diameter steno~s at fortow-up (FU). 
In all vessels, S achieved a better acute gain, net gain anti lower %OS 
as compared to PTCA. However, acute gain was the lowest in LAD, and 
therefore %DS post procedure the highest in LAD. Late loss was greater 
in the S Itrespec~ve of the vessel, with ~ highest late loss for the LAD. 
The restanosis rate was lower In S as cempared to PTCA but nevertheleas 
higher in the LAD. The event rate was lowast in the S gatients as compared 
to PTCA ~ ,  with the LAD yle~ng the highest event rate compared to 
RCA/LCX. 
Conclusion: a l~h S prey)de better a r~ io  and din)cat outcomes 
compared to PTCA, the risk of events and restenosis is more pronounced in 
the LAD when compared to RCA/LCX. 
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['7--'~-'-2-1 Predictors of late Mortality Following Ablative 
New-Device Angtopinsty In Native Coronary Arteries 
Simon R. Redwood, Jeffrey J. Popma, Kenneth M. Kent, Aegtmte 
D. Pichard, Loweg F. Satfar, Gary S. Mintz, Mun K. Hnog, Thamsa 
A. Buchar, Alan J. IVlarr~ Martin B. Leon. Washir~on ~-~ Center 
Washington, DC 
We have previously repoded that 'minor" CPK-MB elevation is associated 
increased late mortality fotlot~g aUath~ new-device angioldasty (NDA) 
in naive coronaries. To determina the iedepandent ~ and causes 
of late moflatity following NDA, we examined the course of lOtS treated 
w~th d~c~onal ae~ectemy (n = 554 lesions), reta~onal ae~ectomy (n 
= 833) and exdmer laser angioplasty (n = 510) between t/90 and 2/94. 
lot)awed for 353 -I- 46 days. The overafl ir~,-,ce of late enoC~ily was 
2.2%. Pt- and lesion-related factors were examined using multivariate logistlc 
regression analysis. Of all variables examined, only post-procedura cute 
renal failure (ARF) and CPK-MB elevation {minor:. > 1 and < 4X nml (ie., 5- 
16 eg/ml):, major > 4X nml (ie., > 17 ng/ml)} were found to be ;c~pc-,-dent 
precrctom of late mortality. Spedf'¢ NDA used was not an independent 
predictor. 
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Incidence Odds ratio 95% CI p 
ARF 6.9=/0 6.3 3.0-13.3 <0.001 
Minor CK-MB rise 29=/° 2.5 1.2-5.5 <0.05 
Maie. CK-MB rise 13% 3.7 1.5-9.2 <0.01 
'Minor' CPK-MB elevation was associated with a threefold increase in 
late mortality (compared with no CPK-MB rise). 70% of these deaths were 
cardiac; causes included arrhythmia in 42% complications of MI in 26'/0, and 
heart failure in 21%. We conclude: Following ablative NDA In native coronary 
arteries: (1) ARF and CPK-MB elevation are independent predictors of late 
mortality and (2) 'minor' CPK-MB elevations are associated with an excess of 
late cardiac deaths, particularly arrhythrnia deaths. The implications of these 
findings warrant further investigation. 
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~ '~-~ Impact of Artery Disease on Right Coronary 
Complications Outing Treatment of the Left 
Coronary System With the Rotsblator 
Mark Reisman, Vema Harms. Swedish Medical Center, Seattle WA 
High speed rotational ablation can transiently affect laft ventricular function 
in the myocardium subtended by the treated vessel. The remaining vessels 
under these oimumstances may play a greater role in hemodynamic Support. 
To assess the complications of muitivessel disease, we analyzed the mufti- 
center registry (n = 3284 pts). We compared pts receiving treatment of the 
either the LAD or circumflex with a significant stenosis in the RCA (> 70%) 
(Group A, n = 331 pts.) with the remaining subset of patients (Group B, n = 
2953 lots). The following rates of complications were observed: 
No rellow Q MI NunQMI CABG Death 
Gr. A 0% t.~/a 7.6% 4.2% 3.4% 
Gr. B 0.5% 12% 5A% 2.5% 1% 
p 0.38 0.79 0.14 0.10 <0.002 
While the rates of non Qweve MI and CABG tended to be higher in Group A 
the differences were not significant. Only the mortality was significantly higher 
in Group A. Of the 331 patients in Group A, 168 had lesions in the RCA of 
70-99.9% while 163 had 100% occlusions. Eleven deaths occurred in this 
group; 8 in the subgroup with 100% occlusion and 3 in the subgroup with 
70-99% lesions of the RCA, p = 0.06. Conclusion: Patients with significant 
right coronary disease appear to be at increased mortality during Rotsblator 
treatment of the left coronary system. 
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~- . - .~  Mechanisms Bradyarrhythmlas Assoc iated With o |  
Rotat ional  Atherectomy 
Gregory A. Braden, Russell J. Bailey, David M. Fitzgerald, Teresa Young, 
Leslie Uttsy, Robert J. Applegate.. Bowman Gray School of Medicine, 
Medical Center Blvd., Winston Salem, NC 
Rotational atherectomy (RA) frequently produces transient bradyarrhythm:as 
(BA) necessitating temporary pacemaker placemenL Etiologies of these ar- 
rhythmlas may include vagat responses or localized adenosine release. We 
studied heart rate responses during RA in 100 consecutive pts in sinus 
rhythm randomized to one cf four groups to receive atropine (AT = 2 mg IV), 
or aminophylline (AM = 5 mg/kg IV) prior to RA: Group A == double placebo 
(pl); Group B = AT+ ph Group C = pl + AM; Group D = AT + AM. Temporary 
pacemakers (PM) were placed in all pts prior to RA, with demand pacing at 
40 bpm. Endpoints included 8A requiring PM, AV block (AVB), heart rate < 
50 bpm at the end of burr runs, and use of dopamine (DP) for hemodynamic 
support. Results: 94 pts randomized had RA performed. Clinical features 
and vessels treated were similar between groups. Discrete variables were 
examined with x 2 tests; "p _ 0.05 vs Group A. 
Group N PM (%) AVB (%) HR < 50 (%) DP (%) 
A 25 40 16 56 24 
B 24 33 21 17 4* 
C 22 36 14 41 27 
D 23 4* 9 9* 4* 
°p _< 0.05 vs Group A. 
Thus, AM and AT alone partially ameliorated the BA during RA, while the 
combination almost completely abolished them. 
Conclusions: Significant BA are common with RA and may require pac- 
ing or pressor support. Both vagal stimulation and adenosine release are 
important mediators of the bradyarrhythmias during RA. 
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7~' ]  Clinical and Anglographlc Predictors of Adverse 
Cardiac Events After Rotsblator Atherectomy 
Jon J. MoJares, Barry M, Kaplan, William W. O'Neill, Venu M. Reddy, Robert 
D. Safian. William Beaumont Hospital, Royal Oak, Michigan 
Rotablator (MRA) was performed in 337 consecutive lesions (309 patients) 
from August 1993 to September 1994 (age 65 • 12 years and 64% male). 
Pre.lntervention ACCIAHA classification was A (5%), B1 (22%), B2 (32%), 
B3 (23%), B4 (8°/o), B5 (1%), and C (9%). 73=/0 of patients had multivessel 
disease and 76% had a myocardial infarction within 3 months. Angiographic 
predictors of major in-hospital cardiac events (7%) including repeat PTCA, 
MI, CABG, and death were final lumen diameter and residual stsnosts after 
adjunctive PTCA (p < 0.05). Adverse events (AE) at 6 and 17 months 
included repeat pamutaneous intervention (21, 30°/=), CABG (8, 10°/o), target 
vessel revascularization ('TVR) (18, 26%), death (5, 12°/,), and any AE (24, 
38°/,). Event-free survival was 76% at 6 months and 62°/, at 1? months. 
Univarets predictors of TVR and AE were: 
TVR AE 
Younger age p < 0.04 p = NS 
Diabetes p = NS p < 0.03 
Hypertension p < 0.05 p < 0.05 
Bifurcation Lesion p < 0.03 p = NS 
Restenosis lesion p = NS p < 0.007 
Smaller elemnce artery size p < 0.05 p < 0.001 
Other variables not predictive of TVR or AE included gender, cholesterol, 
smoking, anginal class, recent MI, number of vessels diseased, calcification, 
dissection grade, lesion length and luminal results. 
Conclusio,'~s: Younger patients with diabetes, hypertension, a bifurcation 
lesion, a restenosis lesion, and small reference artery size were more likely to 
have adverse events after MRA. A smaller final minimal lumen diameter and 
increased final stenosis were associated with increased in-hospital events, 
but did not predict adverse events during follow up. 
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~ Compl icat ions  With New Angloplasty Oevlces. Are  
These Device Speci f ic?  
Sameer Mehta, Jeffrey Popma, James R. Margolis, Linda Moore, Oscar 
R. Pena. Miami Heart Institute, Miami Beach, FL 
Thrombus, dissection, spasm, perforation, distal embolization, and abrupt 
closure are complications associated with the use of New Angioplasty De- 
vices (NAD). To determine if these adverse outcomes are.NAD specific, 
data from 2233 native cemnary lesions treated with NAD in the NACI Reg- 
istry Angiographic Core Laboratory were examined. NAD included in the 
analysis were Directio.qal Atherectomy (DVI), Extraction Atherectomy (rEC), 
Rotablator (ROTA), Palmatz Schatz Stent (PSS) and Excimer Lasers (AIS, 
SPEC). 
DVl TEC ROTA PSS AIS SPEC 
Thrombus 12 2.1 3.7 0 '~ 1 3.2 
Spasm 0.8 0 4,8 1.2 :-,8 1.1 
Embolism 1.9 0 2.8 0 1.4 0 
Abr. Closure 1.3 8,3 3,7 0 7.4 1.1 
Dissection 9.4 25.0 147 6.5 31.7 33,0 
Perforation < 1 4.2 < 1 0 3,2 3.2 
Conclusions: (1) Excimer Lasers (AIS, SPEC) are associated with in- 
creased rates of dissection and thrombus (AIS), Rotablator with increased 
spasm and embolism and TEC htherectomy with more frequent abrupt cin- 
sure and perforation rates. (2) Anticipation of these device specific adverse 
outcomes may be helpful in their management. 
